Sun Pharmaceutical Industries Ltd (SUN.NS)
* Sun Pharma & ICGEB announce new exclusive collaboration to develop novel dengue vaccine for India & global markets
Europe's top court will rule on Thursday whether Danish drugmaker Lundbeck breached EU antitrust rules by paying smaller rivals to delay generic copies of its blockbuster citalopram anti-depressant from entering the market.
BRUSSELS, Sept 6 Europe's top court will rule on Thursday whether Danish drugmaker Lundbeck breached EU antitrust rules by paying smaller rivals to delay generic copies of its blockbuster citalopram anti-depressant from entering the market.
MUMBAI, Aug 12 Sun Pharmaceutical Industries Ltd , India's largest drugmaker, reported a quarterly profit that beat analysts' estimates, helped by its exclusive launch of the first generic version of leukaemia drug Gleevec in the United States.
SAO PAULO Teva Pharmaceutical Industries Ltd and Mylan NV have shown preliminary interest in a Brazilian generic drugmaking joint-venture in which Pfizer Inc has a 40 percent stake, two people familiar with the process said.
MUMBAI, June 8 India's Sun Pharmaceutical Industries Ltd said on Wednesday it had entered the dermatology segment as part of an initiative to further expand its retail offerings.
To access the newsletter, click on the link: http://share.thomsonreuters.com/assets/newsletters/Indiamorning/MNC_IN_06012016.pdf FACTORS TO WATCH 10:30 am: Federal cabinet likely to meet in New Delhi. Agenda not given. GMF: ASIA LIVECHAT - MARKETS FOCUS with Michael Every, Head of Financial Markets Research-Asia-Pacific, Rabobank Lots happening in Asia. While China seems to have cooled down a bit, we have the the BOJ piling on suprises nearly every policy meet. Also
MUMBAI, May 31 India's largest drugmaker Sun Pharmaceutical Industries Ltd reported a near-doubling in fourth-quarter profit, although that missed analysts' estimates as weakness in emerging markets outweighed higher sales in India and the United States.